Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi’s Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi’s Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. East Asian Americans are underrepresented in biopharma companies’ C-suites, a report shows. And more.
Fierce Pharma Asia—Takeda's next CEO; Enhertu's novel FDA nod; East Asian American C-suite execs
Latest articles
Asian technology
Stock market today: Wall Street poised to open higher after government says inflation still stubborn
Wall Street pointed higher early Friday as more strong earnings results trickled in along...
Asian politics
Bangladesh and Pakistan Are Changing South Asia’s Geopolitical Landscape – The Diplomat
Since the overthrow of Sheikh Hasina’s authoritarian rule in August of 2024, two shifts in the...
Asian technology
Stock market today: Asian stocks mostly higher after Wall Street tech gains -January 31, 2025 at 02:27 am EST
HONG KONG (AP) — Asia markets are mostly higher on Friday following gains on...
Asian technology
Stock market today: Asian stocks mostly higher after Wall Street tech gains
Asia markets are mostly higher following gains on Wall Street driven by Tesla, IBM...
More like this
Asian News
State police investigate home burglaries in Hudson Valley targeting Asian American residents
New York State Police are investigating a string of home burglaries in the Hudson...
Asian News
CAPE, TAAF Launch Rising Filmmakers Finishing Fund for Directors
Two nonprofits are teaming up to help fledgling filmmakers finish their films. Coalition of...
Asian News
Review | In Blob: A Love Story, an Asian-American woman literally moulds her perfect man
With the rise of artificial intelligence and the uncertain geopolitical environment, it seems appropriate...